Lymphoma & Plasma Cell Disorders
News
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.
News
ASCO announces its own COVID-19 and cancer registry
ASCO aims to learn how COVID-19 is impacting cancer patients’ treatment and outcomes.
News
Cancer prevalence among COVID-19 patients may be higher than previously reported
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
News
Home-based chemo skyrockets at one U.S. center
The University of Pennsylvania’s home-based chemotherapy program experienced a 300% increase in participation in a 5-week period.
Article
Managing pediatric heme/onc departments during the pandemic
An international group has devised a plan for preventing the spread of infection, treating COVID-19, and adjusting cancer treatments.
Article
Conducting cancer trials amid the COVID-19 pandemic
News
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.
Conference Coverage
20% with cancer on checkpoint inhibitors get thyroid dysfunction
Researchers report more than double the rate of hypothyroidism and more than triple the rate of hyperthyroidism, compared with rates in published...
News
Maintaining cancer care in the face of COVID-19
Oncologists are moving cancer patients to other hospitals, reevaluating the need for cancer treatments, and embracing telemedicine to protect...
News
Blood test might detect multiple cancer types, study suggests
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
